MedGenie is a Swiss and United States corporation with its registered MedGenie AG , office in Bottingen/Basel, the heart of the Swiss pharmaceutical and biotech industries and its affiliate Medgenie, inc in the USA centrally located in Southern California.
To revolutionize patient safety and personalized medicine by integrating pharmacogenomic data with individual genomic profiles and providing innovative medication labeling methods similar to the human Iris that transform how safety information is communicated and improve patient understanding of the safety data as it related to them personally.
By integrating pharmacogenomic data with individual genomic profiles and providing easy to understand safety information to patients
Michael Forstner, PhD
President of Medgenie AG Switzerland
Israel Gutierrez, MD, FRSM, FRSPH
CEO Medgenie Inc